Mycobacterium tuberculosis, the bacterium responsible for tuberculosis, is an obligate human pathogen, meaning it cannot complete its life cycle outside of people. Its continued existence as a species therefore depends entirely on its ability to spread from one host to another, which it accomplishes when infected individuals release bacteria-laden aerosol droplets into the air through coughing, speaking, or breathing. Yet despite the obvious centrality of transmission to the pathogen’s biology, scientists have lacked detailed knowledge of the specific traits that support it. This gap is notable given the scale of the disease: tuberculosis remains one of the deadliest infectious diseases in the world, killing well over a million people each year, and the rise of drug-resistant strains has complicated control efforts in many countries. The new study addresses the transmission gap by focusing on a physical challenge the bacteria inevitably face during spread: desiccation, or drying out, which occurs as aerosol droplets shrink and evaporate in the air.

The research team, led by Christopher D. Brown and Kyu Y. Rhee of Weill Cornell Medicine along with collaborators including Brendon M. Lee, Hannah M. Liu, Amy M. Wu, and structural biologists Seth A. Darst and Elizabeth A. Campbell of The Rockefeller University, designed a laboratory system to mimic this environmental stress. They mounted M. tuberculosis atop a filter platform and exposed the bacteria to varying degrees of humidity, allowing them to model the drying that aerosolized bacteria would experience in the real world. By then rehydrating the samples, the researchers could study not only how the bacteria respond to drying but also how they recover when moisture returns, a scenario that mirrors what happens when droplets are inhaled and reach the warm, moist environment of a new host’s airways. The approach gave the team a controlled, repeatable way to isolate a single transmission-associated stress, something that is nearly impossible to do in studies of naturally transmitted infections, where the conditions of spread cannot be directly observed.

Using transcriptomic analysis, which measures the activity of thousands of genes simultaneously, and metabolomic profiling, which captures the chemical state of cellular metabolism, the researchers charted the molecular consequences of desiccation and rehydration. The results were striking. Dried bacteria showed elevated levels of oxidative stress, a condition in which reactive molecules damage cellular components. Consistent with that stress, the team detected increased oxidative damage and, critically, an accumulation of double-stranded DNA breaks, among the most dangerous forms of genetic injury a cell can sustain. Double-stranded breaks sever both strands of the DNA helix at once, and if left unrepaired they can be lethal to the cell. In response, the bacteria activated DNA repair programs, indicating that the ability to mend a damaged genome is required for survival through the drying and rehydration cycle.

Among the genes whose expression increased during desiccation was mfd, which encodes a transcription-coupled repair factor. Mfd is a protein that patrols genes as they are being transcribed, flagging DNA damage encountered by the transcription machinery and recruiting repair enzymes to those sites. Because actively transcribed genes are particularly vulnerable to damage, and because unrepaired lesions in transcribed regions can stall the enzymes that read DNA into RNA, transcription-coupled repair provides an efficient first line of defense. Its upregulation under dry conditions suggested that Mfd might play a particularly important role in helping M. tuberculosis cope with the genomic insults of transmission. What the researchers discovered next, however, went beyond simple repair and touched directly on one of the most consequential issues in tuberculosis treatment: antibiotic resistance.

Some mutations in rpoB, the gene encoding a subunit of bacterial RNA polymerase, confer resistance to rifampin, a cornerstone drug of standard tuberculosis therapy. Rifampin is central to the standard multidrug regimen, and resistance to it is a key trigger for classifying a case as multidrug-resistant tuberculosis. These resistance mutations, while advantageous in the presence of the antibiotic, often carry a fitness cost, meaning that bacteria bearing them may grow or survive less well than drug-susceptible counterparts under normal conditions. The team found that mfd expression buffered this fitness cost for specific resistance-conferring rpoB mutations. In other words, the very repair factor induced by the stresses of drying appeared to mask the biological disadvantages that rifampin-resistance mutations would otherwise impose, allowing resistant bacteria to persist more effectively.

To test this idea in a transmission-relevant setting, the researchers silenced mfd during aerosolization of the bacteria. The result was highly specific: strains carrying S450L, the most common rifampin resistance allele found in clinical settings, were disproportionately impaired in their ability to survive the aerosolization process when mfd was absent, while the survival of other strains was less affected. This experiment linked the environmental stress of transmission directly to the differential survival of drug-resistant bacteria, suggesting that the physical journey between hosts is not a neutral event for resistant mutants but a selective filter in which Mfd plays a decisive role.

The epidemiological significance of this laboratory finding was reinforced by an analysis of whole-genome sequences from 51,229 clinically circulating strains of M. tuberculosis. This large-scale survey of real-world bacterial populations provided supporting evidence that the interplay between desiccation responses, DNA repair, and resistance mutations observed in the laboratory is reflected in the patterns of strains actually spreading among patients. Whole-genome sequencing has increasingly been used to track tuberculosis outbreaks and map the spread of resistant lineages, and datasets of this size allow researchers to test whether mechanisms discovered at the bench leave detectable signatures in natural populations. While the study does not establish that desiccation is the sole or even primary driver of rifampin resistance in the clinic, the consistency between the mechanistic experiments and the population-level data strengthens the argument that transmission-associated biology matters for resistance.

Taken together, the studies suggest a provocative reframing of how antibiotic resistance may arise and spread in tuberculosis. Desiccation-induced DNA damage during the generation of aerosol droplets may act as a source of genetic diversification, generating mutations that can, under the right circumstances, potentiate antibiotic resistance. At the same time, the upregulation of Mfd may allow bacteria that have already acquired resistance mutations to survive the rigors of transmission that would otherwise cull them. In this model, the act of spreading between hosts, rather than merely serving as a conduit for pre-existing resistant strains, actively participates in shaping the genetic landscape of the pathogen population. Transmission becomes a bottleneck with evolutionary consequences: only bacteria equipped to withstand drying, and to repair the damage drying causes, pass through it successfully.

The work builds on decades of research into DNA repair systems in bacteria. Mfd-dependent transcription-coupled repair is among the most evolutionarily conserved bacterial repair pathways, and it has been studied primarily in model organisms such as Escherichia coli, where it is known to promote both accurate repair and, in some contexts, mutagenesis. That dual character is relevant here: a repair pathway that generates or tolerates mutation while preserving survival can, under antibiotic pressure, inadvertently favor the emergence of resistant variants. The new findings add an ecological and epidemiological dimension to this basic biology, connecting a housekeeping molecular function to the population dynamics of a global pathogen under a stress condition, drying, that is inseparable from how the pathogen moves through the world.

The implications extend to public health strategy. Rifampin-resistant tuberculosis, including multidrug-resistant forms of the disease, requires longer, more toxic, and more expensive treatment regimens, and the continued emergence of resistance threatens the gains made against the epidemic over recent decades. If the biology of transmission contributes to the survival and spread of resistant strains, then interventions that alter transmission conditions, or approaches that target the DNA damage response itself, could in principle complement existing antibiotic strategies. Such strategies would sit alongside established tools such as rapid molecular diagnostics that detect rifampin resistance, airborne infection control in health facilities, and preventive therapy for exposed contacts. The study’s authors suggest that transmission-associated desiccation-induced DNA damage should be considered a potential source of genetic diversification that can potentiate antibiotic resistance, a conclusion that reframes transmission as a bottleneck with evolutionary consequences rather than a passive relay.

Several limitations and open questions remain. The laboratory system used filter-mounted bacteria exposed to controlled humidity, which approximates but does not fully reproduce the complex physical environment of a real aerosol droplet traveling between hosts, where factors such as droplet composition, temperature, light exposure, and air currents all vary. The findings concern a defined set of rpoB mutations, with S450L as the focal allele, and the extent to which Mfd buffers the costs of other resistance mutations, or of resistance to drugs other than rifampin, awaits further study. The epidemiological analysis, while large, is correlational in nature and cannot by itself prove causation. Nonetheless, by identifying a concrete molecular mechanism, Mfd-mediated buffering of resistance-mutation costs during a transmission-relevant stress, and by validating it against a large clinical dataset, the study provides a credible framework for future investigations into how the environment between hosts shapes the evolution of one of humanity’s oldest pathogens.

Future work is likely to explore whether other repair factors contribute to survival during desiccation, whether the DNA damage generated during drying produces specific mutational signatures detectable in circulating strains, and whether pharmacological or environmental interventions could disrupt the desiccation-repair-resistance axis. Answering those questions could help determine whether targeting Mfd or the broader DNA damage response is a realistic avenue for new tuberculosis therapeutics. For now, the study stands as a reminder that the life of a pathogen between its hosts is not a dormant interlude but an active, stressful, and evolutionarily consequential phase of its existence, one that may quietly influence the trajectory of drug resistance worldwide.

A cutting-edge study led by Dr. Kevin Josue Rome at the Hackensack Meridian Center for Discovery and Innovation (CDI) provides an unprecedented genetic exploration of the mechanisms behind A. baumannii’s resistance to Cefiderocol. Published in Microbiology Spectrum, this research employs a comprehensive genome-wide transposon mutagenesis approach combined with detailed genomic and phenotypic analyses of clinically isolated strains that have developed resistance. By moving beyond traditional single-mechanism studies, this work illuminates the multifaceted strategies that A. baumannii harnesses to neutralize what was once considered a powerful antibiotic defense.

Cefiderocol’s innovative mechanism of action relies on its ability to imitate a bacterial siderophore, which bacteria typically produce to scavenge iron from their environment. By hijacking these iron uptake pathways, Cefiderocol achieves efficient bacterial cell entry, targeting crucial penicillin-binding proteins to inhibit cell wall synthesis. Despite its ingenious design and approval in 2019 for treating complicated infections caused by multidrug-resistant organisms, resistance to Cefiderocol has alarmingly already been documented in clinical contexts.

Dr. Rome and his colleagues recognized that isolated examination of specific resistance elements failed to capture the complexity of evolving bacterial defenses. Their large-scale, unbiased transposon mutagenesis survey disrupted thousands of genes to systematically identify mutations that confer variable degrees of resistance. This genome-wide screening unearthed previously unappreciated genetic determinants, revealing how diverse biological pathways collectively orchestrate Cefiderocol resistance.

Significantly, their findings demonstrate that resistance is not merely the consequence of changes in the iron transport system but involves an intricate interplay among multiple molecular processes. These include alterations in efflux pump regulation, modification of antibiotic target sites, shifts in membrane permeability, and activation of stress response pathways. Through convergent mechanisms, A. baumannii effectively reduces drug accumulation and neutralizes Cefiderocol’s bactericidal impact—presenting formidable obstacles for clinical treatment.

The study’s integration of phenotypic assessments with genomics allowed the researchers to correlate specific mutations with measurable shifts in drug susceptibility. They also compared resistant clinical isolates against susceptible counterparts, pinpointing genetic signatures associated with emergent resistance in real-world patient infections. This holistic viewpoint affords a broader mechanistic framework that not only explains current resistance patterns but also offers predictive insight into how resistance may develop in the future.

Beyond its scientific significance, this research carries vital public health implications: it emphasizes the necessity of vigilant, integrated surveillance programs capable of detecting and characterizing resistance early. Given that A. baumannii infections predominantly affect vulnerable hospital populations, understanding these genetic underpinnings is critical for developing informed antibiotic stewardship and containment policies.

The authors underline that preserving the clinical utility of Cefiderocol demands multifaceted strategies. These could encompass combination therapies that mitigate resistance emergence, as well as novel drug design exploiting vulnerabilities identified by this genomic atlas. Further investigation into underlying resistance pathways might also reveal targets for adjuvant compounds that disable bacterial defense mechanisms, potentially restoring antibiotic efficacy.

This work was supported in part by Shionogi & Co., Ltd., reflecting a collaborative effort between academic researchers and pharmaceutical partners. Additionally, funding from the National Institutes of Health underscores the importance of sustained investment in antimicrobial resistance research.

By dissecting the genetic complexity behind Cefiderocol resistance in Acinetobacter baumannii, Dr. Rome’s team delivers crucial knowledge essential for outpacing one of the most formidable challenges in infectious diseases. Their innovative methodology and resulting framework mark a transformative advance in understanding bacterial evolution against last-line antibiotics, offering hope for developing next-generation solutions in the fight against multidrug-resistant superbugs.

Researchers and clinicians are encouraged to delve into the full paper for a detailed exposition of the methodologies and findings that could shape future approaches to combating A. baumannii and preserving the effectiveness of critical antibiotics like Cefiderocol.

Subject of Research: Cells

Article Title: Genetic basis of cefiderocol resistance in Acinetobacter baumannii: insights from functional genomics and clinical isolates

News Publication Date: 9-Feb-2026

Web References:

• PubMed – Genetic Basis of Cefiderocol Resistance
• DOI Link

References:
Rome, K.J., Kreiswirth, B., et al. (2026). Genetic basis of cefiderocol resistance in Acinetobacter baumannii: insights from functional genomics and clinical isolates. Microbiology Spectrum. DOI: 10.1128/spectrum.03804-25

Image Credits: Hackensack Meridian Health

Keywords: Bacteriology, Molecular biology

Plasmids, which are extrachromosomal DNA elements capable of horizontal transfer between bacterial cells, play a pivotal role in disseminating genes that confer resistance to antibiotics. The study reveals that a relatively small subset of these plasmids functions as major vectors, driving the multidrug resistance crisis troubling modern medicine. Historically, plasmids did not initially carry resistance genes; instead, their acquisition of antimicrobial resistance traits occurred after the widespread introduction of antibiotics in the 20th century, underscoring the profound impact of human pharmaceutical practices on bacterial evolution.

By tapping into bacterial collections dating back to 1917, predating the antibiotic era, researchers traced the origins and evolutionary trajectories of plasmids pivotal to current resistance trends. They discovered that ancestral plasmids lacked resistance genes but gradually incorporated these genetic sequences in response to selective pressures imposed by antibiotic usage. These evolutionary adaptations have culminated in “modern plasmids” highly adept at conferring bacterial resistance not only to early-line treatments but also to critical last-resort antibiotics, amplifying the threat to global public health.

The team developed an evolutionary model that categorizes plasmid trajectories into three distinct pathways. The first involves the incremental acquisition of antimicrobial resistance genes into existing plasmid frameworks. The second pathway entails the fusion of distinct plasmids, resulting in composite plasmids that exhibit enhanced transferability across diverse bacterial species. The third pathway, less directly implicated in resistance dissemination, involves plasmid degradation and gene fragment recycling within bacterial populations. Both the gene insertion and plasmid fusion pathways have given rise to the most clinically significant resistant plasmids observed today.

A striking discovery was the demonstration that fusion-derived plasmids exhibit broad host ranges, facilitating the interspecies horizontal gene transfer of resistance determinants. This finding highlights the adaptive versatility of plasmids and the formidable challenge they pose in controlling the spread of resistance. Targeting these “super plasmids” harboring multiple resistance genes might pave the way for innovative therapeutic strategies aimed at curbing multidrug-resistant infections that currently cause over a million deaths annually worldwide.

Crucially, the model developed extends beyond retrospective insight, providing a predictive framework for plasmid evolution over the next century. This approach could enable epidemiologists and public health officials to anticipate emerging resistance patterns and infectious disease outbreaks with greater accuracy. Consequently, it offers a vital tool to guide effective stewardship of antibiotic use and bolster global efforts in curbing antimicrobial resistance proliferation.

Dr. Adrian Cazares, lead author from the Wellcome Sanger Institute, emphasized the transformative nature of these findings on our understanding of bacterial adaptation. “Our research uncovers how antibiotic use has reshaped plasmid genetics, turning a minority into highly efficient agents of resistance spread,” he explained. Such evolutionary pressures, largely anthropogenic, underscore the urgency of reevaluating antibiotic deployment policies.

Complementing this, Professor Zamin Iqbal of the University of Bath highlighted the intricate evolutionary dynamics of plasmids, including slow genetic drift, plasmid fusion events, and genetic recycling. These trends illustrate how microbial genomic plasticity fosters resilience under selective pressures, with human antibiotic consumption acting as a dominant force influencing plasmid diversity and functionality.

Furthermore, Dr. Sarah Alexander from the UK Health Security Agency praised the collaboration’s integration of historical bacterial archives, such as the Murray Collection, that, through rigorous preservation techniques, ensured faithful genetic representations of early 20th-century bacterial strains. This enabled the team to conduct authentic genomic comparisons across an expansive temporal scale, anchoring their evolutionary model in empirical data.

Professor Nick Thomson, co-senior author at the Wellcome Sanger Institute, reflected on the importance of combining historical microbiological archives with modern genomics. The decades-spanning samples illuminated molecular events underlying resistance emergence, offering a rare glimpse into the evolutionary mechanisms that continue to challenge contemporary medicine. The detailed understanding of plasmid evolution could eventually inform targeted interventions aimed at halting the unstoppable march of antibiotic resistance genes.

The societal implications of this research are profound. With antibiotic resistance threatening modern therapeutic paradigms, uncovering the genetic basis and evolution of resistance vectors is essential for developing rational strategies to mitigate their spread. Plasmid-targeted therapies may provide a novel frontier, accompanying traditional antibiotic treatments, that could safeguard efficacy and extend the lifespan of existing drugs.

This study exemplifies the power of integrated multidisciplinary science—melding genomics, evolutionary biology, microbiology, and epidemiology—in addressing one of humanity’s most pressing health crises. As antibiotic resistance continues to evolve rapidly, this research offers both a cautionary tale of past human impacts on microbial genomes and a hopeful pathway for future scientific and clinical innovation.

The findings underscore the urgent need for global coordinated action in antibiotic stewardship, infection control, and ongoing surveillance of resistance elements. By unveiling the molecular players driving multidrug resistance dissemination, researchers empower the medical community with knowledge critical for designing next-generation interventions to protect public health.

Subject of Research: Genetic mechanisms and evolutionary pathways driving the spread of multidrug resistance plasmids in bacteria over the past century.

Article Title: Pre and Post Antibiotic Epoch: The Historical Spread of Antimicrobial Resistance

News Publication Date: 25 September 2025

Web References:

• DOI: 10.1126/science.adr1522
• Global Burden of AMR Study in The Lancet

References:
A. Cazares, W. Figueroa, D. Cazares, et al. (2025). Pre and Post Antibiotic Epoch: The Historical Spread of Antimicrobial Resistance. Science. DOI: 10.1126/science.adr1522.
Naghavi, M., et al. (2024). Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050. The Lancet.

Keywords: Antibiotic resistance, Drug resistance, Bacteria, Plasmids, Mobile genetic elements, Evolutionary biology